Dr. Anna Goc, et al., published, “Inhibition of Borrelia Burgdorferi-Induced TLR2-NFκB Canonical Signaling by Gallic Acid through Targeting the CD14+ Adaptor Protein and p65 Molecule” in International Journal of Molecular Sciences on September 20, 2022. With the goal of discovering novel agents that work against B. burgdorferi, the researchers assessed the anti-Borrelia and anti-inflammatory effects of the phenolic compound, gallic acid.
Search Results for: Borrelia
Medical and Clinical Research published Alan B. MacDonald’s review article, “Microbial DNA globular liquid crystal-like deposits inside Lewy bodies in four Lewy dementia patients,” on August 10, 2022. Through review, […]
Elizabeth M. Hammond, et al., published a study investigating the correlation between persistent Borrelia burgdorferi (Bb), infections, and CD4 T cell responses in Current Opinion in Immunology.
A recent study published in Ticks and Tick-Borne Diseases compared the efficacy of transmission routes, both horizontal (between life stages of developing ticks) and transovarial (from infected female tick to […]
A study conducted by Elizabeth M. Hammond, et al., examining CD4 T cell responses associated with persistent B. burgdorferi (Bb) infections, has been published in Current Opinion in Immunology.
Nature Microbiology recently published an article where researchers identified a sugar that influences cell wall function in Borrelia spirochetes. Authors state that Borrelia burgdorferi bacteria produces glycan chains in the […]
Karvonen, et al., published, “Distinctive Evasion Mechanisms to Allow Persistence of Borrelia burgdorferi in Different Human Cell Lines,” in Frontiers in Microbiology. The study aimed to better understand the mechanisms which enable Borrelia burgdorferi infections to progress into a persistent sequela of the disease by examining two non-immune and non-phagocytic human cell lines.